919 | RTP
RTF ON THE MOVE HEADQUARTERS RELOCATING TO FRONTIER RTP CAMPUS
Research Triangle Foundation – stewards of the land and amenities in Research Triangle Park – is relocating its headquarters from 12 Davis Drive to the Frontier RTP campus. The move unites the team in one central location at 700 Park Offices Drive. The new space is being designed by O’Brien Atkins Associates, and will include energetic meeting spaces that will allow RTF to continue in its role as a convener of its companies, universities and partners at the center of the Triangle. The move is also expected to enable RTF to maintain closer contact with its tenants and partners, placing it adjacent to both the Hub RTP development project and the recently-opened Boxyard RTP. “As development at Hub continues, it has become clear that our team needs to be closer to the action,” saidScott Levitan, President and CEO of RTF. “Additionally, as we seek ways to more intentionally engage with RTP companies and our partners, it makes sense for our offices to be in this accessible, connected location.” The move is also a response to an organizational assessment conducted in 2020. “Staff development and feedback are core to our organization’s success, and some of the key findings from that exercise were requests to unite our team and culture under one roof,” said Linda Hall, Executive Vice President and CFO at RTF. “We look forward to creating a more collaborative shared environment where our team can do its best work.” RTF expects to move into the new space in 2022; until then, the team will operate from 800 Park Offices Drive. For more information, visit rtp.org
DEPARTING RTP
GSK HEALTHCARE PLANS RELOCATION TO DURHAM GlaxoSmithKline plans to leave its 561,652-square-foot Research Triangle Park campus by 2022. GSK – in the location since 1972 – employs about 1,300 at RTP and indicated the move will not involve job losses. The company plans to relocate to a smaller space at the American Tobacco Campus in downtown Durham.
42
We look forward to creating a more collaborative shared environment where our team can do its best work. LINDA HALL RTF Executive Vice President and CFO
RTP EXPANSION
STRIDEBIO ADDS LAB, MANUFACTURING SPACE StrideBio Inc., a developer of novel adeno-associated viral based gene therapies, recently completed its new 8,700 sq. ft. in-house manufacturing and an additional 15,000 sq. ft. expansion of its laboratory and office spaces in Research Triangle Park. “Since closing our most recent $81.5M Series B financing in March of this year, we have been focused on continuing to build the team and infrastructure necessary to execute and achieve critical milestones as we seek to advance
www.919Magazine.com
therapeutic programs into the clinic,” said Sapan Shah, Ph.D., Chief Executive Officer, StrideBio, Inc. “We are thrilled to announce the hiring of our 100th Strider (employee) and the vital expansions to StrideBio’s laboratory and GMP manufacturing facilities, which will ensure our novel engineered capsids that address current challenges with existing vectors have an opportunity to benefit patients,” For more information, visit stridebio.com.
November/December 2021
